Greenwich Street

Lazard Announces Total Consideration for Lazard Group LLC’s Cash Tender Offer for Its 3.750% Senior Notes Due 2025

Retrieved on: 
Tuesday, March 12, 2024

Per $1,000 principal amount of Notes validly tendered and not validly withdrawn pursuant to the Tender Offer.

Key Points: 
  • Per $1,000 principal amount of Notes validly tendered and not validly withdrawn pursuant to the Tender Offer.
  • Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures.
  • The closing of the Tender Offer is subject to the satisfaction or waiver of certain conditions as set forth in the Offer to Purchase.
  • Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amount of their Notes to tender.

BNY Mellon 2024 Annual Meeting of Stockholders

Retrieved on: 
Tuesday, March 26, 2024

NEW YORK, March 26, 2024 /PRNewswire/ -- BNY Mellon (NYSE: BK) will hold the 2024 Annual Meeting of Stockholders at 240 Greenwich Street, New York, New York 10286 on Tuesday, April 9, 2024, at 9:00 a.m.

Key Points: 
  • NEW YORK, March 26, 2024 /PRNewswire/ -- BNY Mellon (NYSE: BK) will hold the 2024 Annual Meeting of Stockholders at 240 Greenwich Street, New York, New York 10286 on Tuesday, April 9, 2024, at 9:00 a.m.
  • The Notice of Annual Meeting and Proxy Statement was made available on February 29, 2024.
  • For more information on registration, see Annual Meeting Q&A in the 2024 Proxy Statement.
  • BNY Mellon will provide a live audio webcast of the Annual Meeting.

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Retrieved on: 
Monday, March 11, 2024

Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announces that the Company’s voluntary delisting of American Depositary Shares (“ADSs”) representing its ordinary shares from The Nasdaq Capital Market (“Nasdaq”) has become effective.

Key Points: 
  • Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announces that the Company’s voluntary delisting of American Depositary Shares (“ADSs”) representing its ordinary shares from The Nasdaq Capital Market (“Nasdaq”) has become effective.
  • The Bank of New York Mellon serves as depositary (the “Depositary”) for the Company’s ADS facility.
  • On or about May 28, 2024, the Depositary may elect to sell the underlying ordinary shares.
  • Investors will receive either the underlying ordinary shares (if those have not yet been sold by the Depositary) or the cash received by the Depositary received upon sale of underlying ordinary shares, net of fees, if those underlying ordinary shares were sold.

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

Retrieved on: 
Tuesday, February 20, 2024

The Company listed the ADSs on The Nasdaq Global Select Market in November 2017 under the ticker ERYP, and subsequently transferred the listing of its ADSs to The Nasdaq Capital Market in April 2023.

Key Points: 
  • The Company listed the ADSs on The Nasdaq Global Select Market in November 2017 under the ticker ERYP, and subsequently transferred the listing of its ADSs to The Nasdaq Capital Market in April 2023.
  • “Given PHAXIAM’s current stage of development, we have determined that delisting from the Nasdaq market was the wisest business and financial decision for the company.
  • PHAXIAM Therapeutics remains listed on Euronext Paris as its primary trading market and intends to continue its disclosures in compliance with applicable French financial market regulations.
  • Investors will receive either the underlying ordinary shares (if those have not yet been sold by the Depositary) or the cash received by the Depositary received upon sale of underlying ordinary shares, net of fees, if those underlying ordinary shares were sold.

Lazard Announces Commencement of Senior Notes Offering and Concurrent Tender Offer by Lazard Group LLC

Retrieved on: 
Wednesday, March 6, 2024

Lazard, Inc. (NYSE: LAZ) announced today that its subsidiary Lazard Group LLC (“Lazard Group”) is commencing an offering (the “Offering”) of one or more series of its senior notes (the “Notes”).

Key Points: 
  • Lazard, Inc. (NYSE: LAZ) announced today that its subsidiary Lazard Group LLC (“Lazard Group”) is commencing an offering (the “Offering”) of one or more series of its senior notes (the “Notes”).
  • The Notes would be senior unsecured obligations of Lazard Group.
  • Concurrently with the Offering, Lazard Group is commencing a cash tender offer (the “Tender Offer”) for any and all of its outstanding 3.750% Senior Notes due February 13, 2025 (the “2025 Notes”).
  • Citigroup Global Markets Inc. and Lazard Frères & Co. LLC are acting as joint lead book-running managers and joint lead managers for the Offering.

Lazard Announces Cash Tender Offer for 3.750% Senior Notes Due 2025 of Lazard Group LLC

Retrieved on: 
Wednesday, March 6, 2024

Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures.

Key Points: 
  • Interest will cease to accrue on the Settlement Date for all Notes accepted for purchase in the Tender Offer, including any such Notes tendered through guaranteed delivery procedures.
  • Citigroup Global Markets Inc. is acting as the lead dealer manager and Lazard Frères & Co. LLC is acting as co-dealer manager (together, the “Dealer Managers”) for the Tender Offer.
  • None of Lazard Group or its affiliates, their respective boards of directors, the Dealer Managers, the Tender Agent, the Information Agent or the trustee for the Notes makes any recommendation as to whether holders should tender any of their Notes.
  • Holders must make their own decision as to whether to tender any of their Notes and, if so, the principal amount of their Notes to tender.

Thor Equities Group Announces Long Term Lease with The Pilecki Institute at 88 Greenwich Street

Retrieved on: 
Monday, February 5, 2024

New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate development, leasing, and management, is pleased to announce a long-term lease with The Pilecki Institute, for 35,000 square feet at 88 Greenwich Street in Downtown Manhattan, marking the Institute’s first location outside of Europe.

Key Points: 
  • New York, NY, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Thor Equities Group, a global leader in real estate development, leasing, and management, is pleased to announce a long-term lease with The Pilecki Institute, for 35,000 square feet at 88 Greenwich Street in Downtown Manhattan, marking the Institute’s first location outside of Europe.
  • The Pilecki Institute, a research and cultural institution founded in 2016, works to preserve the remembrance, documentation, and research of the historical experiences of Polish citizens, while increasing awareness regarding totalitarianism in the 20th century.
  • “The Pilecki Institute’s decision to open at 88 Greenwich is a testament to the building’s excellent location and underscores the importance of having a presence in the New York City market,” Chief Operating Officer of Thor Equities Group, Melissa Gliatta.
  • “We are pleased to welcome them to their new home and support their important mission.”
    Regular Coffee has also signed a long term lease at 88 Greenwich Street and is planning to open early this year in a 1,500 square feet space.

Nano Labs Announced Updates to Holders of ADRs Regarding Amendment to the Deposit Agreement and Termination of ADR Facility

Retrieved on: 
Wednesday, January 3, 2024

1 to the Deposit Agreement, and (y) a form of ADR that reflects the additional termination provision with the U.S. Securities and Exchange Commission (the "SEC") under cover of Post-Effective Amendment No.

Key Points: 
  • 1 to the Deposit Agreement, and (y) a form of ADR that reflects the additional termination provision with the U.S. Securities and Exchange Commission (the "SEC") under cover of Post-Effective Amendment No.
  • HEREBY GIVES NOTICE OF THE TERMINATION OF THE AMERICAN DEPOSITARY RECEIPTS FACILITY FOR THE ADSs EFFECTIVE AS OF THE TERMINATION DATE.
  • After effectuating the Mandatory Exchange, the Depositary shall be discharged from all obligations under the Deposit Agreement with respect to the ADRs, the Deposited Securities and the ADSs under the Deposit Agreement.
  • If you have any questions about the above termination and Mandatory Exchange, please call Citibank ADR Shareholder Services at 1-877-248-4237.

VNET Announces the Completion of US$299 Million Strategic Investment from Shandong Hi-Speed Holdings Group Limited and the Repurchase Right Notification for 0.00% Convertible Senior Notes due 2026

Retrieved on: 
Thursday, December 28, 2023

Separately, the Company is notifying holders of its 0.00% Convertible Senior Notes due 2026 (CUSIP No.

Key Points: 
  • Separately, the Company is notifying holders of its 0.00% Convertible Senior Notes due 2026 (CUSIP No.
  • The Repurchase Right entitles each holder of the Notes to require the Company to repurchase all of such holder's Notes, or any portion thereof that is an integral multiple of the US$1,000 principal amount.
  • Holders of the Notes should refer to the Indenture for a complete description of repurchase procedures.
  • Materials filed with the SEC will be available electronically without charge at the SEC's website, http://www.sec.gov .

The Perfect Blend: Kinder Bueno® and Lavazza Join Forces to Celebrate National Coffee Day

Retrieved on: 
Friday, September 22, 2023

PARSIPPANY, N.J., Sept. 22, 2023 /PRNewswire/ -- Kinder Bueno®, the crispy, creamy chocolate bar known for its unique taste experience that defies expectation, is teaming up with Lavazza, the iconic coffee company, to celebrate National Coffee Day. To commemorate the new pairing, fans of both brands have the chance to receive a FREE Kinder Bueno bar and a FREE Lavazza Cappuccino Cold Brew through their co-branded "Unrush Mobile Coffee Shop" on Friday, September 29, at the following locations and times: World Trade Center (250 Greenwich Street) from 9:30am – 1:30pm and South Street Seaport (96 South Street) from 2:30pm – 6:30pm. Those who stop by will be able to sit, sip and savor their coffee moments like they've never "bean" able to before.

Key Points: 
  • To help consumers relish in their coffee moments with Kinder Bueno, the brand is teaming up with world renowned, family-owned coffee company, Lavazza .
  • To help consumers savor their coffee moments, Kinder Bueno and Lavazza are giving away a one-year supply of Kinder Bueno bars and Lavazza Classico Coffee.
  • Consumers must be 18 years or older and a United States resident to participate in the Kinder Bueno and Lavazza National Coffee Day giveaway.
  • Consumers can also visit Amazon.com and save 20% when they buy any Lavazza coffee and Kinder Bueno bars.